Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia

Internal Medicine

Volumn 48, Issue 16, 2009, Pages 1391-1395

  Osuka, Akinori ^a   Matsuoka, Tetsuya ^a   Idoguchi, Koji ^a  

^a National Hospital Organization   (Japan)

Author keywords

Diabetic ketoacidosis; Hypertriglyceridemia; Hypophosphatemia; Malignant hyperthermia like syndrome; Metabolic syndrome

Indexed keywords

CREATINE KINASE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY; PHOSPHATE;

ABDOMINAL CIRCUMFERENCE; ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ANTHROPOMETRIC PARAMETERS; ANURIA; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRADYCARDIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DECOMPRESSION SURGERY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET; DISEASE DURATION; FATTY LIVER; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HEART ARREST; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOPHOSPHATEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; KETONURIA; LIVER DYSFUNCTION; MALE; MENTAL DETERIORATION; METABOLIC ACIDOSIS; METABOLIC SYNDROME X; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREATITIS; PLASMAPHERESIS; SUBSTITUTION THERAPY;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; HEART ARREST; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOPHOSPHATEMIA; INSULIN; MALE; METABOLIC SYNDROME X; PHOSPHATES; TREATMENT OUTCOME;

EID: 70349551398     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2236     Document Type: Article

References (22)

1. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 45: 851-858, 2005.
2. Haglin L. Hypophosphataemia: cause of the disturbed metabolism in the metabolic syndrome. Med Hypotheses 56: 657-663, 2001.
3. Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 79: 9-37, 1995.
4. Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism 28: 191-194, 1979.
5. Bohannon NJ. Large phosphate shifts with treatment for hyperglycemia. Arch Intern Med 149: 1423-1425, 1989.
6. Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. Am J Emerg Med 11: 77-80, 1993.
7. Kyriakidis AV, Karydakis P, Neofytou N, et al. Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases. Pancreatology 5: 201-204, 2005.
8. Piolot A, Nadler F, Cavallero E, et al. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 13: 96-99, 1996.
9. Gravelyn TR, Brophy N, Siegert C, et al. Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population. Am J Med 84: 870-876, 1988.
10. Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 137: 203-220, 1977.
11. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57: 177-180, 1983.
12. Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes 29: 87-95, 1980.
13. Wilson HK, Keuer SP, Lea AS, et al. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 142: 517-520, 1982.
14. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in diabetes. Diabetes Care 27 Suppl 1: S94-S102, 2004.
15. Bollaert PE, Levy B, Nace L, Laterre PF, Larcan A. Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 107: 1698-1701, 1995.
16. Knochel JP. Hypophosphatemia. West J Med 134: 15-26, 1981.
17. Fuller TJ, Nichols WW, Brenner BJ, Peterson JC. Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency. J Clin Invest 62: 1194-1200, 1978.
18. Capasso JM, Aronson RS, Strobeck JE, Sonnenblick EH. Effects of experimental phosphate deficiency on action potential characteristics and contractile performance of rat myocardium. Cardiovasc Res 16: 71-79, 1982.
19. 2 output induced by bicarbonate infusion. Minerva Anestesiol 66: 627-633, 2000.
20. Knochel JP, Barcenas C, Cotton JR, Fuller TJ, Haller R, Carter NW. Hypophosphatemia and rhabdomyolysis. Trans Assoc Am Physicians 91: 156-168, 1978.
21. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369: 1823-1831, 2007.
22. Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics 111: 1447-1452, 2003.